{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:36:59Z","timestamp":1753893419573,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017837","name":"Wuxi Science and Technology Association","doi-asserted-by":"publisher","award":["N20192016"],"award-info":[{"award-number":["N20192016"]}],"id":[{"id":"10.13039\/100017837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> PBRM1 gene abnormalities were recently found to play a role in tumor development and tumor immune activity. This article will explore the clinicopathological and molecular changes and tumor immune activity of the abnormal SWI\/SNF complex subunit PBRM1 in gastric adenocarcinoma (GAC) and its significance.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The cBioPortal, LinkedOmics and TISIDB datasets were used to analyze the abnormality of the PBRM1 gene in GAC and its relationship with prognosis, related molecular changes and tumor-infiltrating lymphocytes (TILs). In addition, 198 GAC cases were collected to further study the relationship between the loss\/attenuation of PBRM1 expression and clinicopathology, prognosis, microsatellite stability, PD-L1 expression and TIL in GAC. DNA whole-exome sequencing was performed on 7 cases of gastric cancer with loss of PBRM1 expression.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The cBioPortal data showed that PBRM1 deletion\/mutation accounted for 7.32% of GAC and was significantly associated with several molecular changes, such as molecular subtypes of GAC. The LinkedOmics dataset showed that PBRM1 mutation and its promoter DNA methylation showed lower PBRM1 mRNA expression, and PBRM1 mutation cases showed significantly higher mRNA expression of PD-L1 (CD274). TISIDB data showed that PBRM1 abnormalities were significantly positively associated with multiple TILs. In our group of 198 cases, the loss\/attenuation of PBRM1 expression was significantly positively correlated with intra-tumoral tumor infiltrating lymphocytes (iTILs) and deficient MMR and PD-L1 expression. Kaplan\u2013Meier survival analysis showed that the overall survival of GAC patients with loss\/attenuation of PBRM1 expression was significantly better (<jats:italic>p<\/jats:italic> = 0.023). iTIL was an independent prognostic factor of GAC. Loss of PBRM1 expression often co-occurs with mutations in other SWI\/SNF complex subunit genes, and there are some repetitive KEGG signaling changes.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Abnormality of the PBRM1 gene may be related to the occurrence of some GACs and can affect tumor immune activity, thereby affecting clinicopathology and prognosis. It may be a potentially effective predictive marker for immunotherapy and a novel therapeutic approach associated with synthetic lethality.<\/jats:p>","DOI":"10.3389\/pore.2022.1610479","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T08:40:26Z","timestamp":1658220026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI\/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma"],"prefix":"10.3389","volume":"28","author":[{"given":"Zhiyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","article-title":"Current Treatment and Recent Progress in Gastric Cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/cas.14311","article-title":"Synthetic Lethal Therapy Based on Targeting the Vulnerability of SWI\/SNF Chromatin Remodeling Complex\u2010deficient Cancers","volume":"111","author":"Sasaki","year":"2020","journal-title":"Cancer Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41467-020-15959-6","article-title":"PBRM1 Loss Defines a Nonimmunogenic Tumor Phenotype Associated with Checkpoint Inhibitor Resistance in Renal Carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"B5","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: Analyzing Multi-Omics Data within and across 32 Cancer Types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: An Integrated Repository portal for Tumor-Immune System Interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0245356","DOI":"10.1371\/journal.pone.0245356","article-title":"The Clinicopathological Significance of SWI\/SNF Alterations in Gastric Cancer Is Associated with the Molecular Subtypes","volume":"16","author":"Huang","year":"2021","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/his.14211","article-title":"Intraepithelial Tumour Infiltrating Lymphocytes Are Associated with Absence of Tumour Budding and Immature\/myxoid Desmoplastic Reaction, and with Better Recurrence\u2010free Survival in Stages I-III Colorectal Cancer","volume":"78","author":"Gonz\u00e1lez","year":"2021","journal-title":"Histopathology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ajcp\/aqz136","article-title":"Prognostic Significance of Stromal and Intraepithelial Tumor-Infiltrating Lymphocytes in Small Intestinal Adenocarcinoma","volume":"153","author":"Jun","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/ijc.31389","article-title":"Genetic and Clonal Dissection of Osteosarcoma Progression and Lung Metastasis","volume":"143","author":"Xu","year":"2018","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.critrevonc.2018.01.009","article-title":"The SWI\/SNF Complex Subunit Genes: Their Functions, Variations, and Links to Risk and Survival Outcomes in Human Cancers","volume":"123","author":"Savas","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gde.2017.02.004","article-title":"Mammalian SWI\/SNF Complexes in Cancer: Emerging Therapeutic Opportunities","volume":"42","author":"Pierre","year":"2017","journal-title":"Curr Opin Genet Dev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e12791","DOI":"10.1111\/cpr.12791","article-title":"The Roles of Mutated SWI\/SNF Complexes in the Initiation and Development of Hepatocellular Carcinoma and its Regulatory Effect on the Immune System: A Review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif"},{"key":"B15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A Major Chromatin Regulator Determines Resistance of Tumor Cells to T Cell-Mediated Killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/neuonc\/noaa004","article-title":"SWI\/SNF Complex Heterogeneity Is Related to Polyphenotypic Differentiation, Prognosis, and Immune Response in Rhabdoid Tumors","volume":"22","author":"Panwalkar","year":"2020","journal-title":"Neuro Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1356144","DOI":"10.1080\/2162402X.2017.1356144","article-title":"Analysis of PD1, PDL1, PDL2 Expression and T Cells Infiltration in 1014 Gastric Cancer Patients","volume":"7","author":"Xing","year":"2017","journal-title":"Oncoimmunology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12094-021-02714-6","article-title":"Tumor Immune Microenvironment Is Influenced by Frameshift Mutations and Tumor Mutational burden in Gastric Cancer","volume":"24","author":"Kim","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jcmgh.2021.01.014","article-title":"Intraepithelial Lymphocytes Suppress Intestinal Tumor Growth by Cell-To-Cell Contact via CD103\/E-Cadherin Signal","volume":"11","author":"Morikawa","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12885-019-6425-3","article-title":"Loss of the SWI\/SNF-ATPase Subunit Members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in Oesophageal Adenocarcinoma","volume":"20","author":"Schallenberg","year":"2020","journal-title":"BMC Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"762598","DOI":"10.3389\/fimmu.2021.762598","article-title":"A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1172\/JCI130445","article-title":"Inhibition of the ATM\/Chk2 axis Promotes cGAS\/STING Signaling in ARID1A-Deficient Tumors","volume":"130","author":"Wang","year":"2020","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","article-title":"ARID1A Deficiency Promotes Mutability and Potentiates Therapeutic Antitumor Immunity Unleashed by Immune Checkpoint Blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2020.09.006","article-title":"The Impact of ARID1A Mutation on Molecular Characteristics in Colorectal Cancer","volume":"140","author":"Tokunaga","year":"2020","journal-title":"Eur J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/cells8070678","article-title":"ARID1A Mutations are Associated with Increased Immune Activity in Gastrointestinal Cancer","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e150453","DOI":"10.1172\/jci.insight.150453","article-title":"SWI\/SNF Complex Alterations as a Biomarker of Immunotherapy Efficacy in Pancreatic Cancer","volume":"6","author":"Botta","year":"2021","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","first-page":"745187","DOI":"10.3389\/fonc.2021.745187","article-title":"The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T08:40:30Z","timestamp":1658220030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":27,"alternative-id":["10.3389\/pore.2022.1610479"],"URL":"https:\/\/doi.org\/10.3389\/pore.2022.1610479","relation":{},"ISSN":["1532-2807"],"issn-type":[{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"article-number":"1610479"}}